Rosa Cabello-Laureano

Rosa Cabello-Laureano

Auto-generated profile, based on publicly available information

Rosa Cabello-Laureano

Servicio de Cirugía Pediátrica, Hospital Virgen del Rocío, Sevilla, España

Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2014 in World Journal of Hepatology
Verified
Journal Article
Closed access
IFIsrael Fernandez-Pineda
Israel Fernandez-Pineda
RCRosa Cabello-Laureano
Rosa Cabello-Laureano
During the first year of life, most of the liver neoplasms are benign in origin, but some of these histologically benign lesions may be challenging in their management. Although most hepatic hemangiomas can be safely observed until involution is documented, some patients will need treatment due to progressive hepatomegaly, hypothyroidism and/or cardiac failure. Large mesenchymal hamartomas may require extensive hepatic resection and an appropriate surgical plan is critical to obtain good results. For malignant neoplasms such as hepatoblastoma, complete surgical resection is the mainstay of curative therapy. The decision about whether to perform an upfront or delayed resection of a primary liver malignant tumor is based on many considerations, including the ease of resection, surgical expertise, tumor histology and stage, and the likely chemosensitivity of the tumor. This article reviews the initial management of the more common hepatic tumors of infancy, focusing on the differential diagnosis and treatment options.

1 October 2013 in Journal of Pediatric Hematology/Oncology
Verified
Journal Article
Closed access
MBMichael Berger
Michael Berger
IFIsrael Fernandez-Pineda
Israel Fernandez-Pineda
RCRosa Cabello
Rosa Cabello
GVGema L Ramírez Villar
Gema L Ramírez Villar
CMCatalina Márquez-Vega
Catalina Márquez-Vega
JHJochen Hubertus
Jochen Hubertus
The aim of this study was to analyze in detail the site of metastasis of stage 4 Wilms tumor (WT) and its correlation with outcome. The databases from 3 major European pediatric cancer institutions were screened for children with WT between 1994 and 2011. Of 208 children identified, 31 (14.9%) had metastases at diagnosis. The lung was affected in 29 children (93.5%) and the liver in 6 children (19.4%). Twenty-seven children (87.1%) had metastases isolated to 1 organ, with the lung being the most common site (80.7%). Five-year overall survival was significantly better in those children with distant disease in either lung or liver (95.8%) compared with those affected in both lung and liver (57.1%, P=0.028). Further, prognostic markers were the response of metastases to preoperative chemotherapy (P=0.0138), high-risk histology (P=0.024), and local stage (P=0.026). Five-year overall survival was 82.1% and 5-year event-free survival was 67.9%. The overall follow-up time was 74.1 and 87.2 (2 to 151) months among survivors, and the treatment-related complication rate was 16.7%. In conclusion, in our series of stage 4 WT, prognosis was excellent if histology was favorable, metastatic disease was isolated to either lungs or liver, and if metastases responded to preoperative chemotherapy.

27 January 2012 in Pediatric Hematology and Oncology
Verified
Journal Article
Closed access
DADiego Aspiazu
Diego Aspiazu
IFIsrael Fernandez-Pineda
Israel Fernandez-Pineda
RCRosa Cabello
Rosa Cabello
GRGema Ramirez
Gema Ramirez
AAAntonio Alvarez-Madrid
Antonio Alvarez-Madrid
JAJuan Carlos De Agustin
Juan Carlos De Agustin
The purpose of this study was to retrospectively analyze the clinical presentation, treatment, and outcomes of children with Wilms tumor (WT) and intravascular extension who were treated at a single institution. A retrospective review was conducted of medical records of all children with Wilms tumor and intravascular extension treated at Virgen del Rocio Children's Hospital between 1992 and 2010. Seven patients (median age 3.4 years, range 2–8.1 years) were identified. At diagnosis, 6 of the 7 patients (85.7%) presented with tumor thrombus that reached the right atrium (RA) and 1 patient with infrahepatic inferior vena cava (IVC) thrombus. All patients received neoadjuvant chemotherapy (SIOP 2001 protocol) with vincristine, doxorubicin, and actinomycin D. Regression of the intravascular extension of the tumor was documented in all patients. Postchemotherapy level of extension was suprahepatic IVC in 1 patient, infrahepatic IVC in 2 patients, renal vein (RV) in 1 patient, and RA in 3 patients. Nephrectomy and thrombectomy were performed in all cases, requiring cardiopulmonary bypass for the 4 patients who presented with suprahepatic IVC and RA thrombus. The other 3 patients with infrahepatic IVC and RV involvement underwent cavotomy and thrombus extraction. Computed tomography, ultrasonography, and echocardiography were used for diagnosis and follow-up. All patients remain disease-free with a median follow-up of 6.3 years (range, 2–19 years). Neoadjuvant chemotherapy for WT with intravascular extension may facilitate the resection by decreasing the extent of the tumor thrombus. Cardiopulmonary bypass is indicated for suprahepatic IVC and RA involvement. Accurate diagnostic imaging is necessary.

1 October 2014 in Pediatrics
Verified
Journal Article
Closed access
PDF file
EGEmilio García-García
Emilio García-García
IDInmaculada Domínguez-Pascual
Inmaculada Domínguez-Pascual
MRMercedes Requena-Díaz
Mercedes Requena-Díaz
RCRosa Cabello-Laureano
Rosa Cabello-Laureano
IFIsrael Fernández-Pineda
Israel Fernández-Pineda
MSMaría J. Sánchez-Martín
María J. Sánchez-Martín
Neonatal severe primary hyperparathyroidism presents in the first days of life with severe life-threatening hypercalcemia. It is associated with an inactivating homozygous mutation of the calcium sensing receptor gene. Total parathyroidectomy is the treatment of choice, so the surgeon must identify all the parathyroid tissue, including supernumerary and ectopic glands. We present the case of an infant who underwent total parathyroidectomy at age 4 months in which intraoperative parathyroid hormone monitoring provided immediate confirmation of surgical cure.

25 November 2011 in Clinical and Translational Oncology
Verified
Journal Article
Closed access
PDF file
IFIsrael Fernandez-Pineda
Israel Fernandez-Pineda
RCRosa Cabello
Rosa Cabello
JGJuan Antonio García-Cantón
Juan Antonio García-Cantón
SPSonia Pérez-Bertolez
Sonia Pérez-Bertolez
ÍTÍñigo Tuduri
Íñigo Tuduri
JAJuan Carlos de Agustín
Juan Carlos de Agustín

1 February 2014 in Cirugía Española
Verified
Journal Article
Closed access
YCYolanda Martínez Criado
Yolanda Martínez Criado
SBSonia Pérez Bertólez
Sonia Pérez Bertólez
RLRosa Cabello Laureano
Rosa Cabello Laureano
JAJuan Carlos de Agustín Asensio
Juan Carlos de Agustín Asensio